Vaccines and inhaled insulin in, erectile dysfunction drugs out of Part D
The Centers for Medicare & Medicaid Services issues a final rule clarifying its position on the inclusion of insulin and exclusion of erectile dysfunction medications in the Medicare Part D program.
The Centers for Medicare & Medicaid Services has issued a final rule clarifying its policies for the Medicare Part D program. According to the rule, devices for the inhalation of insulin will now be included in the program. In addition, any drug when used for the treatment of sexual or erectile dysfunction is excluded from the program. Among other changes the rule also ensures payment for administration of covered vaccines. The final rule was published in the April 15 Federal Register.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
